Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
نویسندگان
چکیده
منابع مشابه
Serious adverse events associated with pediatric complementary and alternative medicine
Serious adverse events associated with pediatric complementary and alternative medicine Liliane Zorzela a,∗,1, Heather Boon b, Silvano Mior c,d, Jerry Yager e, Anita Gross f, Sunita Vohra a a Department of Pediatrics, University of Alberta, Canada b Leslie Dan Faculty of Pharmacy, University of Toronto, Canada c Graduate Education and Research, Canadian Memorial Chiropractic College, Canada d U...
متن کاملSerious adverse events associated with yellow fever vaccine
Yellow fever vaccine was considered one of the safest vaccines, but in recent years it was found that it could rarely cause invasive and disseminated disease in some otherwise healthy individuals, with high lethality. After extensive studies, although some risk factors have been identified, the real cause of causes of this serious adverse event are largely unknown, but findings point to individ...
متن کاملRegular treatment with formoterol for chronic asthma: serious adverse events.
BACKGROUND Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe. OBJECTIVES The aim of this review is to assess the risk of fatal and non-fatal serious adverse events in trials that randomised patien...
متن کاملAdverse events associated with ERCP.
Vinay Chandrasekhara, MD, Mouen A. Khashab, MD, V. Raman Muthusamy, MD, FASGE, Ruben D. Acosta, MD, Deepak Agrawal, MD, MPH, David H. Bruining, MD, Mohamad A. Eloubeidi, MD, MHS, FASGE, Robert D. Fanelli, MD, FACS, FASGE, SAGES Representative, Ashley L. Faulx, MD, FASGE, Suryakanth R. Gurudu, MD, FASGE, Shivangi Kothari, MD, Jenifer R. Lightdale, MD, MPH, FASGE, NASPGHAN Representative, Bashar ...
متن کاملBisphosphonate-associated adverse events.
The adverse events of the nitrogen-containing bisphosphonates are reviewed. Oral bisphosphonates (alendronate, risedronate and ibandronate), mainly used for the treatment of osteoporosis, have been associated with adverse events from the upper gastrointestinal tract, acute phase response, hypocalcaemia and secondary hyperparathyroidism, musculoskeletal pain, osteonecrosis of the jaw and ocular ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal for ImmunoTherapy of Cancer
سال: 2019
ISSN: 2051-1426
DOI: 10.1186/s40425-018-0487-7